Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis

29 Apr 2015

Abstract excerpt

AIM: To explore whether the aberrant DNA methylation status in plasma could be used as a biomarker for hepatocellular carcinoma (HCC) screening among high-risk individuals. METHODS: The promoter methylation status of ELF, RASSF1A, p16, and GSTP1 was investigated by methylation-specific polymerase chain reaction (PCR) in 34 paired HCC and nontumor liver tissue from HCC patients and 10 tissues from patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25923138
DOI: 10.1089/gtmb.2014.0292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of DNA Methylation in Plasma for Monitoring HepatocarcinogenesisPMID 25923138Read ↗

Genome-wide DNA methylation profiles in hepatocellular carcinomaSemantic proximity Read ↗

Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNASemantic proximity Read ↗

Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general populationSemantic proximity Read ↗

CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.Semantic proximity Read ↗

Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular CarcinomaSemantic proximity Read ↗

Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinomaSemantic proximity Read ↗

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.Semantic proximity Read ↗

Clinical implications of DNA methylation in hepatocellular carcinoma.Semantic proximity Read ↗

Disease Progression from Chronic Hepatitis C to Cirrhosis and Hepatocellular Carcinoma is Associated with Increasing DNA Promoter MethylationSemantic proximity Read ↗

Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosisSemantic proximity Read ↗

Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.